PulseSight Therapeutics SAS, an ophthalmology biotech company developing disruptive non-viral vectorized therapies with minimally-invasive delivery technology, today announces it has submitted a ...
GOTHENBURG, SE / ACCESSWIRE / January 14, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, January 14, 2025 - IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company that disc ...
The expiry date on your study permit tells you when you have to stop studying and leave Canada. You can find the expiry date under additional information on your study permit. This date is usually the ...
A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.
Karolinska Development AB (Nasdaq Stockholm: KDEV) today announces that its portfolio company AnaCardio has secured SEK 205 million in a series A extension financing round and reports positive results ...